An official American Thoracic Society systematic review

Insurance status and disparities in lung cancer practices and outcomes

Christopher G. Slatore, David H. Au, Michael K. Gould

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Rationale: Insurance coverage is an important determinant of access to care and is one potential cause of disparities in lung cancer care outcomes. Objectives: We performed a systematic review of the available literature to examine the association between insurance status and lung cancer practices and outcomes. Methods: We searched multiple electronic databases through November 6, 2008 for studies that examined the association between lung cancer outcomes and insurance status. Two reviewers independently selected studies. One investigator evaluated their quality according to predetermined criteria, and abstracted data about study design, patients' demographic and clinical characteristics, and outcome measures. Measurements and Main Results: Of 3,798 potentially relevant studies, 23 met eligibility criteria and were included. Studies reported heterogeneous outcomes among heterogeneous samples of patients that precluded a quantitative synthesis. In general, compared with patients with private or Medicare insurance, patients with Medicaid or no insurance had poorer lung cancer outcomes, including higher incidence rates, later stage at diagnosis, and poorer survival. Overall, patients with Medicaid or no insurance were less likely to undergo curative procedures, but patients without insurance were more likely to receive guideline-concordant care. Conclusions: Patients with Medicaid or no insurance consistently had worse outcomes than other patients with lung cancer. Some of the disparities may be secondary to residual confounding from smoking and other health behaviors, but available data suggest that patients with lung cancer without insurance do poorly because access to care is limited and/or they present with more advanced disease that is less amenable to treatment.

Original languageEnglish (US)
Pages (from-to)1195-1205
Number of pages11
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume182
Issue number9
DOIs
StatePublished - Nov 1 2010

Fingerprint

Insurance Coverage
Lung Neoplasms
Insurance
Medicaid
Health Behavior
Medicare
Smoking
Research Personnel
Demography
Outcome Assessment (Health Care)
Databases
Guidelines
Survival
Incidence

Keywords

  • Disparities
  • Insurance
  • Lung cancer

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

@article{a8c050299d4e4866bbafe618ec3d44d2,
title = "An official American Thoracic Society systematic review: Insurance status and disparities in lung cancer practices and outcomes",
abstract = "Rationale: Insurance coverage is an important determinant of access to care and is one potential cause of disparities in lung cancer care outcomes. Objectives: We performed a systematic review of the available literature to examine the association between insurance status and lung cancer practices and outcomes. Methods: We searched multiple electronic databases through November 6, 2008 for studies that examined the association between lung cancer outcomes and insurance status. Two reviewers independently selected studies. One investigator evaluated their quality according to predetermined criteria, and abstracted data about study design, patients' demographic and clinical characteristics, and outcome measures. Measurements and Main Results: Of 3,798 potentially relevant studies, 23 met eligibility criteria and were included. Studies reported heterogeneous outcomes among heterogeneous samples of patients that precluded a quantitative synthesis. In general, compared with patients with private or Medicare insurance, patients with Medicaid or no insurance had poorer lung cancer outcomes, including higher incidence rates, later stage at diagnosis, and poorer survival. Overall, patients with Medicaid or no insurance were less likely to undergo curative procedures, but patients without insurance were more likely to receive guideline-concordant care. Conclusions: Patients with Medicaid or no insurance consistently had worse outcomes than other patients with lung cancer. Some of the disparities may be secondary to residual confounding from smoking and other health behaviors, but available data suggest that patients with lung cancer without insurance do poorly because access to care is limited and/or they present with more advanced disease that is less amenable to treatment.",
keywords = "Disparities, Insurance, Lung cancer",
author = "Slatore, {Christopher G.} and Au, {David H.} and Gould, {Michael K.}",
year = "2010",
month = "11",
day = "1",
doi = "10.1164/rccm.2009-038ST",
language = "English (US)",
volume = "182",
pages = "1195--1205",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "9",

}

TY - JOUR

T1 - An official American Thoracic Society systematic review

T2 - Insurance status and disparities in lung cancer practices and outcomes

AU - Slatore, Christopher G.

AU - Au, David H.

AU - Gould, Michael K.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Rationale: Insurance coverage is an important determinant of access to care and is one potential cause of disparities in lung cancer care outcomes. Objectives: We performed a systematic review of the available literature to examine the association between insurance status and lung cancer practices and outcomes. Methods: We searched multiple electronic databases through November 6, 2008 for studies that examined the association between lung cancer outcomes and insurance status. Two reviewers independently selected studies. One investigator evaluated their quality according to predetermined criteria, and abstracted data about study design, patients' demographic and clinical characteristics, and outcome measures. Measurements and Main Results: Of 3,798 potentially relevant studies, 23 met eligibility criteria and were included. Studies reported heterogeneous outcomes among heterogeneous samples of patients that precluded a quantitative synthesis. In general, compared with patients with private or Medicare insurance, patients with Medicaid or no insurance had poorer lung cancer outcomes, including higher incidence rates, later stage at diagnosis, and poorer survival. Overall, patients with Medicaid or no insurance were less likely to undergo curative procedures, but patients without insurance were more likely to receive guideline-concordant care. Conclusions: Patients with Medicaid or no insurance consistently had worse outcomes than other patients with lung cancer. Some of the disparities may be secondary to residual confounding from smoking and other health behaviors, but available data suggest that patients with lung cancer without insurance do poorly because access to care is limited and/or they present with more advanced disease that is less amenable to treatment.

AB - Rationale: Insurance coverage is an important determinant of access to care and is one potential cause of disparities in lung cancer care outcomes. Objectives: We performed a systematic review of the available literature to examine the association between insurance status and lung cancer practices and outcomes. Methods: We searched multiple electronic databases through November 6, 2008 for studies that examined the association between lung cancer outcomes and insurance status. Two reviewers independently selected studies. One investigator evaluated their quality according to predetermined criteria, and abstracted data about study design, patients' demographic and clinical characteristics, and outcome measures. Measurements and Main Results: Of 3,798 potentially relevant studies, 23 met eligibility criteria and were included. Studies reported heterogeneous outcomes among heterogeneous samples of patients that precluded a quantitative synthesis. In general, compared with patients with private or Medicare insurance, patients with Medicaid or no insurance had poorer lung cancer outcomes, including higher incidence rates, later stage at diagnosis, and poorer survival. Overall, patients with Medicaid or no insurance were less likely to undergo curative procedures, but patients without insurance were more likely to receive guideline-concordant care. Conclusions: Patients with Medicaid or no insurance consistently had worse outcomes than other patients with lung cancer. Some of the disparities may be secondary to residual confounding from smoking and other health behaviors, but available data suggest that patients with lung cancer without insurance do poorly because access to care is limited and/or they present with more advanced disease that is less amenable to treatment.

KW - Disparities

KW - Insurance

KW - Lung cancer

UR - http://www.scopus.com/inward/record.url?scp=78349275747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349275747&partnerID=8YFLogxK

U2 - 10.1164/rccm.2009-038ST

DO - 10.1164/rccm.2009-038ST

M3 - Article

VL - 182

SP - 1195

EP - 1205

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 9

ER -